Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Rashi Raghulan

3PUBLICATIONS

82CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Feb 11, 2026

Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-Refractory KRASG12C-Mutant NSCLC for Immune Checkpoint Blockade.

Xing Wei, Cristina Blaj, M Ali Al-Radhawi

|Apr 29, 2025

A RAS(ON) Multi-Selective Inhibitor Combination Therapy Triggers Long-term Tumor Control through Senescence-Associated Tumor-Immune Equilibrium in Pancreatic Ductal Adenocarcinoma.

Caroline Broderick, Riccardo Mezzadra, Exequiel M Sisso

|Jul 08, 2024

Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS-Mutant Non-Small Cell Lung Cancer.

Haniel A Araujo, Ximo Pechuan-Jorge, Teng Zhou

Pageof 1

Frequent Collaborators

3 joint publications

Ximo Pechuan-Jorge

3 joint publications

Mallika Singh

3 joint publications

Jingjing Jiang

2 joint publications

Lingyan Jiang

2 joint publications

Jacqueline A M Smith

2 joint publications

Elsa Quintana

2 joint publications

Nataliya Tovbis Shifrin

2 joint publications

Mariela A Moreno Ayala

1 joint publications

Haniel A Araujo

1 joint publications

Xin Hu

Frequent Collaborators

3 joint publications

Ximo Pechuan-Jorge

3 joint publications

Mallika Singh

3 joint publications

Jingjing Jiang

2 joint publications

Lingyan Jiang

Top Related Videos

Identification of EGFR and RAS Inhibitors using <em>Caenorhabditis elegans</em>

Identification of EGFR and RAS Inhibitors using <em>Caenorhabditis elegans</em>

Published on : Oct 05, 2020

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos

Top Related Videos

Identification of EGFR and RAS Inhibitors using <em>Caenorhabditis elegans</em>

Identification of EGFR and RAS Inhibitors using <em>Caenorhabditis elegans</em>

Published on : Oct 05, 2020

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos